MithraGen's Other Investors

MithraGen raised a round of funding on , . Investors include BCM Technologies.

MithraGen develops immunotherapies for T and B cells for the treatment and prevention of cancers and infectious diseases. It offers RetroVax, a product platform technology, which turns antigen contain…

Articles about MithraGen's Other Investors: